ECS Botanics is selling for under 0.017 as of the 22nd of December 2024; that is 6.25 percent increase since the beginning of the trading day. The stock's last reported lowest price was 0.017. ECS Botanics has a very small chance of experiencing financial distress in the next few years but had a somewhat weak performance during the last 90 days. ECS Botanics has reported 15 for 1 split on 26th of November 2024. The performance scores are derived for the period starting the 2nd of January 2023 and ending today, the 22nd of December 2024. Click here to learn more.
ECS Botanics is entity of Australia. It is traded as Stock on AU exchange. The company has 1.3 B outstanding shares. More on ECS Botanics Holdings
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. ECS Botanics' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding ECS Botanics or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
ECS Botanics' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to ECS Botanics' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Debt LevelsECS Botanics can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand ECS Botanics' financial leverage. It provides some insight into what part of ECS Botanics' total assets is financed by creditors.
LiquidityECS Botanics cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. ECS Botanics Holdings has accumulated 1.02 M in total debt. Debt can assist ECS Botanics until it has trouble settling it off, either with new capital or with free cash flow. So, ECS Botanics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like ECS Botanics Holdings sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for ECS to invest in growth at high rates of return. When we think about ECS Botanics' use of debt, we should always consider it together with cash and equity.
ECS Botanics Holdings (ECS) is traded on Australian Securities Exchange in Australia and employs 9 people. ECS Botanics is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 22.03 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate ECS Botanics's market, we take the total number of its shares issued and multiply it by ECS Botanics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. ECS Botanics Holdings operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 1.3 B outstanding shares.
ECS Botanics Holdings has accumulated about 1.87 M in cash with (1.49 M) of positive cash flow from operations.
Check ECS Botanics Probability Of BankruptcyOwnership AllocationECS Botanics holds a total of 1.3 Billion outstanding shares. ECS Botanics Holdings retains substantial amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the entity is less than the current market value, you may not be able to make money on it.
Check ECS Ownership Details
ECS Botanics Holdings Risk Profiles
Although ECS Botanics' alpha and beta are two of the key measurements used to evaluate ECS Botanics' performance over the market, the standard measures of volatility play an important role as well.
Our tools can tell you how much better you can do entering a position in ECS Botanics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run Sectors Now
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Elected by the shareholders, the ECS Botanics' board of directors comprises two types of representatives: ECS Botanics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ECS. The board's role is to monitor ECS Botanics' management team and ensure that shareholders' interests are well served. ECS Botanics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ECS Botanics' outside directors are responsible for providing unbiased perspectives on the board's policies.
When running ECS Botanics' price analysis, check to measure ECS Botanics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ECS Botanics is operating at the current time. Most of ECS Botanics' value examination focuses on studying past and present price action to predict the probability of ECS Botanics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ECS Botanics' price. Additionally, you may evaluate how the addition of ECS Botanics to your portfolios can decrease your overall portfolio volatility.